Optimizing thiopurine therapy in inflamm
β
Jean-Baptiste Chevaux; Laurent Peyrin-Biroulet; Miles P. Sparrow
π
Article
π
2011
π
John Wiley and Sons
π
English
β 113 KB
Despite recent advances, the therapeutic armamentarium for inflammatory bowel disease (IBD) is still limited. In addition, a step-up approach is recommended for most IBD patients. Thus, optimizing each medical therapy before switching to another drug class is the rule in clinical practice. Conventio